Egg Yolk Powder Composition for Muscle Loss and Mobility in Aging Mammals

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Aging and chronically ill mammals experience muscle loss, weakness, stiffness, decreased energy, and decreased mobility, which negatively affect their quality of life and activity, and existing supplements do not adequately address these issues.

Innovation Solution

Administration of a composition comprising egg yolk powder, such as FORTETROPIN, which includes proteins and lipids derived from egg yolk, to alleviate and inhibit negative age-related or illness-related effects, including muscle loss, weakness, stiffness, and decreased mobility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional supplements (glucosamine, green-lipped mussel, chondroitin, omega-3 fatty acids) are administered to aging mammals, then joint structure and function are supported, but muscle loss, weakness, and decreased energy are not adequately addressed

Engineering Contradiction:
Improvejoint structure and functionVSAvoidcomprehensive anti-aging effect
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines multiple beneficial components into a single composition: egg yolk powder (rich in proteins and lipids), omega-3 fatty acids, and other nutrients. This merging approach allows the composition to simultaneously support joint structure while addressing muscle loss, weakness, and energy depletion that traditional single-purpose supplements cannot address comprehensively

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The egg yolk powder composition is designed to perform multiple functions: supporting joint structure and cartilage health, reducing muscle loss, combating weakness, increasing energy levels, and improving overall mobility. This multi-functional approach resolves the limitation of traditional supplements that target only specific aspects of aging

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Quantity of substance

If aging mammals receive conventional nutritional support, then basic nutritional needs are met, but quality of life and activity levels significantly decline

Engineering Contradiction:
Improvenutritional intakeVSAvoidmobility and activity
Core Design Contradiction:
Quantity of substanceVSEase of operation

Solution Approach 1:

The patent changes the nutritional parameters by introducing egg yolk powder with specific protein and lipid compositions that differ from conventional supplements. The high-quality proteins and essential fatty acids in egg yolk powder are designed to improve muscle maintenance and energy metabolism, thereby enhancing mobility and activity levels beyond what standard nutritional intake provides

Inventive Principle:
Principle #35Parameter changes

3Stability of the object's composition

If supplements target joint health specifically, then cartilage and connective tissue are maintained, but overall quality of life and energy levels are not sufficiently improved

Engineering Contradiction:
Improvecartilage and connective tissue healthVSAvoidenergy levels and activity
Core Design Contradiction:
Stability of the object's compositionVSUse of energy by moving object

Solution Approach 1:

The composition merges joint-supporting components with energy-boosting nutrients. Egg yolk powder provides high-quality proteins for cartilage maintenance while simultaneously supplying essential fatty acids and other nutrients that support energy metabolism, muscle function, and overall vitality, addressing both structural and functional aspects of aging

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS12478656B2Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammals
Publication Date: 2025.11.25 MYOS CORP

AI summary

Methods for improving quality of life and/or increasing activity in an aging and/or chronically ill mammal via administration of a composition of egg powder protein are provided.